Royal Fund Management, LLC Zynerba Pharmaceuticals, Inc. Transaction History

Royal Fund Management, LLC

  • $1.66 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 06, 2020
SELL
$3.31 - $6.54 $165 - $327
-50 Closed
0 $0
Q4 2019

May 11, 2020
BUY
$5.61 - $8.57 $280 - $428
50 New
50 $0
Q3 2018

May 07, 2020
SELL
$5.59 - $10.45 $139 - $261
-25 Closed
0 $0
Q2 2018

May 07, 2020
BUY
$7.98 - $12.39 $199 - $309
25 New
25 $0

Others Institutions Holding ZYNE

# of Institutions
4
Shares Held
774K
Call Options Held
0
Put Options Held
0
View Full List

About Zynerba Pharmaceuticals, Inc.

ZYNE Quotes by TradingView
  • Ticker ZYNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,753,100
  • Description
  • Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...
More about ZYNE
Track This Portfolio

Track Royal Fund Management, LLC Portfolio

Follow Royal Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Royal Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email